neurological disorders

Myelin Oligodendrocyte Glycoprotein (MOG) Antibodies in the Cerebrospinal Fluid of Pediatric Patients With MOG Antibody-Associated Disease: Insights From an Asian Multicenter Cohort

MOG Antibody-Associated Disease Overview Myelin Oligodendrocyte Glycoprotein (MOG) antibodies are increasingly recognized as significant biomarkers in a subset of neurological

Myelin Oligodendrocyte Glycoprotein (MOG) Antibodies in the Cerebrospinal Fluid of Pediatric Patients With MOG Antibody-Associated Disease: Insights From an Asian Multicenter Cohort Read Post »

Myelin Oligodendrocyte Glycoprotein (MOG) Antibodies in the Cerebrospinal Fluid of Pediatric Patients With MOG Antibody-Associated Disease: Insights From an Asian Multicenter Cohort

Study Overview In recent years, the understanding of autoimmune conditions affecting the central nervous system has advanced, highlighting the role

Myelin Oligodendrocyte Glycoprotein (MOG) Antibodies in the Cerebrospinal Fluid of Pediatric Patients With MOG Antibody-Associated Disease: Insights From an Asian Multicenter Cohort Read Post »

Scroll to Top